Peter Merrick Kistler

Peter Merrick Kistler

Auto-generated profile, based on publicly available information

Peter Merrick Kistler

The Alfred Hospital, Melbourne, Australia; The Baker Heart and Diabetes Research Institute, Melbourne, Australia; University of Melbourne, Melbourne, Australia; Monash University, Melbourne, Australia; Cabrini Malvern Hospital, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in JACC
Verified
Journal Article
Closed access
SPSandeep Prabhu
Sandeep Prabhu
ATAndrew J. Taylor
Andrew J. Taylor
BCBen T. Costello
Ben T. Costello
DKDavid M. Kaye
David M. Kaye
AMAlex J.A. McLellan
Alex J.A. McLellan
PKPeter M. Kistler
Peter M. Kistler

10 January 2023 in JAMA
Verified
Journal Article
Open access
PDF file
PKPeter M. Kistler
Peter M. Kistler
DCDavid Chieng
David Chieng
HSHariharan Sugumar
Hariharan Sugumar
LLLiang-Han Ling
Liang-Han Ling
LSLouise Segan
Louise Segan
JKJonathan M. Kalman
Jonathan M. Kalman
Importance: Pulmonary vein isolation (PVI) alone is less effective in patients with persistent atrial fibrillation (AF) compared with paroxysmal AF. The left atrial posterior wall may contribute to maintenance of persistent AF, and posterior wall isolation (PWI) is a common PVI adjunct. However, PWI has not been subjected to randomized comparison.Objective: To compare PVI with PWI vs PVI alone in patients with persistent AF undergoing first-time catheter ablation.Design, Setting, and Participants: Investigator initiated, multicenter, randomized clinical trial involving 11 centers in 3 countries (Australia, Canada, UK). Symptomatic patients with persistent AF were randomized 1:1 to either PVI with PWI or PVI alone. Patients were enrolled July 2018-March 2021, with 1-year follow-up completed March 2022.Interventions: The PVI with PWI group (n = 170) underwent wide antral pulmonary vein isolation followed by posterior wall isolation involving linear ablation at the roof and floor to achieve electrical isolation. The PVI-alone group (n = 168) underwent wide antral pulmonary vein isolation alone.Main Outcomes and Measures: Primary end point was freedom from any documented atrial arrhythmia of more than 30 seconds without antiarrhythmic medication at 12 months, after a single ablation procedure. The 23 secondary outcomes included freedom from atrial arrhythmia with/without antiarrhythmic medication after multiple procedures, freedom from symptomatic AF with/without antiarrhythmic medication after multiple procedures, AF burden between study groups at 12 months, procedural outcomes, and complications.Results: Among 338 patients randomized (median age, 65.6 [IQR, 13.1] years; 76.9% men), 330 (97.6%) completed the study. After 12 months, 89 patients (52.4%) assigned to PVI with PWI were free from recurrent atrial arrhythmia without antiarrhythmic medication after a single procedure, compared with 90 (53.6%) assigned to PVI alone (between-group difference, –1.2%; hazard ratio [HR], 0.99 [95% CI, 0.73-1.36]; P = .98). Of the secondary end points, 9 showed no significant difference, including freedom from atrial arrhythmia with/without antiarrhythmic medication after multiple procedures (58.2% for PVI with PWI vs 60.1% for PVI alone; HR, 1.10 [95% CI, 0.79-1.55]; P = .57), freedom from symptomatic AF with/without antiarrhythmic medication after multiple procedures (68.2% vs 72%; HR, 1.20 [95% CI, 0.80-1.78]; P = .36) or AF burden (0% [IQR, 0%-2.3%] vs 0% [IQR, 0%-2.8%], P = .47). Mean procedural times (142 [SD, 69] vs 121 [SD, 57] minutes, P < .001) and ablation times (34 [SD, 21] vs 28 [SD, 12] minutes, P < .001) were significantly shorter for PVI alone. There were 6 complications for PVI with PWI and 4 for PVI alone.Conclusions and Relevance: In patients undergoing first-time catheter ablation for persistent AF, the addition of PWI to PVI alone did not significantly improve freedom from atrial arrhythmia at 12 months compared with PVI alone. These findings do not support the empirical inclusion of PWI for ablation of persistent AF.Trial Registration: anzctr.org.au Identifier: ACTRN12616001436460

2 January 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
AVAleksandr Voskoboinik
Aleksandr Voskoboinik
JKJonathan M. Kalman
Jonathan M. Kalman
ASAnurika De Silva
Anurika De Silva
TNThomas Nicholls
Thomas Nicholls
BCBenedict Costello
Benedict Costello
PKPeter M. Kistler
Peter M. Kistler
Excessive alcohol consumption is associated with incident atrial fibrillation and adverse atrial remodeling; however, the effect of abstinence from alcohol on secondary prevention of atrial fibrillation is unclear.

1 October 2018 in Heart, Lung and Circulation
Verified
Journal Article
Open access
JAJohn Atherton
John Atherton
ASAndrew Sindone
Andrew Sindone
CPCarmine G. De Pasquale
Carmine G. De Pasquale
ADAndrea Driscoll
Andrea Driscoll
PMPeter S. MacDonald
Peter S. MacDonald
CCCia Connell
Cia Connell

1 July 2004 in JACC
Verified
Journal Article
Closed access
PKPeter M Kistler
Peter M Kistler
PSPrashanthan Sanders
Prashanthan Sanders
SFSimon P Fynn
Simon P Fynn
ISIrene H Stevenson
Irene H Stevenson
SSSteven J Spence
Steven J Spence
JKJonathan M Kalman
Jonathan M Kalman

1 September 2006 in JACC
Verified
Journal Article
Closed access
PKPeter M. Kistler
Peter M. Kistler
KRKurt C. Roberts-Thomson
Kurt C. Roberts-Thomson
HHHaris M. Haqqani
Haris M. Haqqani
SFSimon P. Fynn
Simon P. Fynn
SSSuresh Singarayar
Suresh Singarayar
JKJonathan M. Kalman
Jonathan M. Kalman